Acute Necrotizing Pancreatitis
14
3
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis
Effectiveness of Endorotor PED® System Versus Conventional Endoscopic Techniques for the Management of Walled-off Pancreatic Necrosis in Acute Necrotizing Pancreatitis: Randomized Single-blinded Controlled Superiority Trial and Cost-utility Analysis
Integrating Plasma Metagenomics and Host Response for Accurate Diagnosis of Infected Pancreatic Necrosis in a Prospective Multicenter Cohort of Acute Necrotizing Pancreatitis
A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
CMV Reactivation in Acute Necrotizing Pancreatitis
Acute Pancreatitis and Thrombosis (PATHRO)
Tracking ENcapsulation of Pancreatic Collections in Acute Necrotizing Pancreatitis
Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis
Risk Factors for ARDS in Patients With Acute Necrotizing Pancreatitis
Plastic Stents vs. NAGI Bi-flanged Metal Stent for Endoscopic Ultrasound Guided Drainage of Walled-off Necrosis
Significance of Collections Around Colon in Patients With Acute Necrotizing Pancreatitis
PancRea: Risk Factors and Outcomes of Infected Pancreatic Necrosis
Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis
Early Enteral Nutrition for Severe Acute Pancreatitis